Flavonoids are bioactive compounds found in foods such as tea, red wine, fruits, and vegetables. 2
INTRODUCTION 23
Flavonoids represent a structurally diverse group of polyphenolic compounds which are 24 synthesized during plant metabolism 1 and are present in many commonly consumed foods 2 . 25 Particular fruits and vegetables, such as blueberries, apples, spinach and onions are considered 26 rich sources of flavonoids. So too are beverages, such as tea and red wine 3 . 27
Meta-analyses have shown that consumption of flavonoid-rich foods are associated with reduced 28 risk of cause-specific mortalities such as those attributable to cancer, diabetes, and 29 cardiovascular disease [4] [5] [6] [7] . Much of the beneficial effects of these foods have been attributed to 30 their high content of biologically active flavonoids, which have been shown to improve nitric 31 oxide homeostasis and endothelial function, and reduce platelet aggregation and oxidative 32 stress [8] [9] [10] [11] [12] [13] . Flavonoids are also thought to play roles in inactivating carcinogens, inducing 33 antiproliferation, cell cycle arrest and apoptosis, and inhibiting angiogenesis 14 . 34
Despite this growing evidence for reduced risk of specific cancer and cardiovascular disease 35 mortalities associated with consumption of flavonoid rich foods, the relationship of flavonoid-36 rich food and flavonoid compound intake with risk of all-cause mortality is less clear. Following 37 the advent of the comprehensive United States Department of Agriculture (USDA) flavonoid-38 class food content database in 2007 15 , the few studies exploring the relation of flavonoid intake 39 with all-cause mortality have yielded inconsistent patterns of association, likely due to 40 insufficient sample size, limited variation in intake, or incomplete food composition table [16] [17] [18] . 41
The varying levels of flavonoid-class intake and different patterns of flavonoid-class intake 42 across countries 19 have also likely contributed to the lack of clarity regarding the relationship 43 between flavonoid-compound intake and risk of all-cause mortality in the population. 44
Furthermore, the role that the whole-food, as distinct from the isolated food-constituent, plays in 45 a score variable based on the median consumption level for each quintile of flavonoid 95 consumption. 96
The multivariable-adjusted model included age, body mass index (BMI), smoking status, 97 menopausal status, family history of diabetes/cancer/myocardial infarction, multivitamin 98 supplement use, aspirin use, race, type 2 diabetes, hypercholesterolemia, hypertension, physical 99 activity, alcohol consumption, and caloric intake. The multivariable plus diet-adjusted model 100 incorporated the multivariable-adjusted model plus the Alternative Healthy Eating Index (minus 101 alcohol) score 26 . 102
For sensitivity analyses, baseline flavonoid intake and unrestricted cumulative average flavonoid 103 intake, where updates continued until death or end of study irrespective of chronic disease 104 diagnosis, were also computed. To address the concern that occult chronic diseases in the years 105 that preceded diagnosis may have influenced dietary intake, we excluded the first 2 years of 106 follow-up data and added a 2-year lag period between flavonoid-intake assessment and each 107 follow-up period. 108
We conducted several additional sensitivity analyses to assess the robustness of the results. To 109 minimize the influence of smoking or an extremely low or high body-mass index on the results, 110 we excluded participants who had ever smoked or who had a BMI of less than 18.5 or more than 111 40 kg/m 2 . We also excluded participants who had diabetes at baseline, and we suspended 112 updating of dietary variables after a diagnosis of diabetes during study follow-up. 113
Analyses were performed with the SAS statistical package (version 9.3, SAS Institute). 114
Statistical tests were two-sided, and P values of less than 0.05 were considered to indicate 115 statistical significance. 116
RESULTS

117
Cohort characteristics 118
At baseline, the mean age of participants was 36. Mean daily total-flavonoid consumption was 379 (±374) mg. Proanthocayanins contribute 57%, 126 and flavan-3-ols 28%, to total-flavonoid intake ( Table 1) . 127
Participants were similar in terms of baseline risk factors across all levels of total-flavonoid 128 consumption. However, high flavonoid consumers were more physically active and were less 129 likely to be current smokers at baseline ( Table 2) . 130
Flavonoid-rich foods and risk of all-cause, and cause specific, mortality 131
We explored potential whole-food contributors by analyzing foods rich in the flavonoid-classes 132 (Figure 1) . Frequent consumption of blueberries, strawberries, apples, peppers, red-wine and tea 133 were all significantly inversely associated with risk of all-cause mortality in age-adjusted, 134 multivariable-adjusted and multivariable-plus-diet-adjusted models. When compared to non-135 consumers, frequent tea and red wine consumption showed the greatest magnitude of reduction 136 in risk. Conversely, when compared to infrequent consumers, risk of all-cause mortality was 137 greater in participants with frequent grapefruit consumption. Continuing to update of intake 138 irrespective of chronic disease diagnosis did not substantially impact results, and results were 139 similar in all sensitivity analyses. 140
In cause-specific age and multivariable-adjusted analyses (Table 3) , when compared to non-141 consumers, the benefit of frequent blueberry and strawberry consumption was restricted to 142 cancer mortality, and the benefit of peppers restricted to mortalities from other-causes. 143
Although not associated with all-cause mortality, frequent orange-fruit consumers were at 144 reduced risk of cancer and other-cause mortalities, respectively. Congruent with the all-cause 145 mortality results, we observed that frequent grapefruit consumers were at increased risk of 146 mortalities from other causes. 147
Both red wine and tea showed the greatest magnitude of benefit in the all-cause mortality 148
analyses. Specifically, in the multivariable-adjusted model, when compared to the non-149 consumers, the relative risk (95% CI) of all-cause mortality for frequent consumers of red wine 150 and tea (more than once per week) was 0.60 (0.49, 0.74), and 0.73 (0.65, 0.83), respectively. 151
When looking at cause-specific mortalities, frequent consumption of red wine and tea was 152 associated with reduced risk of both cancer and other-cause mortalities, in both age-adjusted and 153 multivariable-adjusted models. Results were not significantly altered in sensitivity analyses. 154
Flavonoid compounds and risk of all-cause, and cause specific, mortality 155
In age-adjusted models, participants in the highest quintile of total-flavonoid consumption were 156 19% (7-29%) less likely to have died in the 18-year follow-up period, when compared to those in 157 the lowest quintile ( Table 4) . Similar beneficial associations were observed with increased 158 consumption of flavan-3-ols, flavonols, flavones, proanthocyanins and anthocyanins, however, 159 relationships were attenuated and no longer statistically significant following multivariable-160 adjustment. Despite multivariable-adjustment substantially attenuating the relationships for 161 proanthocyanins and anthocyanidins, no one factor in the multivariable-adjusted model was 162 responsible for attenuation of the findings. Results were not significantly altered in sensitivity 163 analyses. 164
We then examined the relation of individual flavonoid classes with cause-specific mortality. In 165 age-adjusted models, when compared to the lowest quintile, participants in the highest quintile of 166 anthocyanin intake were at lower risk of mortality from cancer, cardiovascular disease and other-167
causes. This beneficial association remained for cancer mortalities following multivariable-168 adjustment ( Table 5 ). Flavan-3-ols and proanthocyanins followed a similar inverse pattern, 169 whereas flavonols, flavanones and flavones showed no association in either the unadjusted or 170 multivariable-adjusted models, with any of the mortality types.
DISCUSSION 172
This prospective cohort study of middle-aged US women found that participants with higher 173 intakes of specific flavonoid-rich foods, namely blueberries, strawberries, peppers, red wine and 174 tea, were associated with reduced risk of all-cause mortality. When exploring contributors to 175 these relationships, the association with all-cause mortality appeared to be largely driven by 176 mortalities from cancer, as well as other causes. These beneficial relations did not extend to the 177 other flavonoid-rich foods, or intakes of flavonoid compounds. 178
Despite null associations at a compound level, numerous significant associations with all-cause 179 mortality were observed for many flavonoid-rich foods. Our finding of a null association of total-180 flavonoid intake with risk of all-cause mortality in US women is congruent with the Iowa 181
Womens' Health Study 17 . However, in our previous analysis in Australian women 16 we observed 182 a strong relation between increased total-flavonoid intake and reduced risk of all-cause mortality. 183
This incongruence in findings between studies, and the differences we observed in associations 184 with compounds and whole foods, is likely explained by the complexity of flavonoid intake 185 assessment and regional differences in the compositional variation in the whole food sources of 186 dietary flavonoids 19 , which in turn shapes the pattern of over 4,000 different flavonoid 187 compounds consumed on a daily basis 27 . 188
When looking at whole-food associations, we observed that increased consumption of 189 blueberries, strawberries, peppers, red wine and tea was associated with reduced risk of all-cause 190 mortality. These associations remained after adjusting for dietary pattern, suggesting that the 191 oxidative stress and inflammation [29] [30] [31] [32] [33] . The strongest beneficial relation with all-cause mortality 195 was observed with the frequency of red wine consumption, which remained even after adjusting 196 for total alcohol consumption, which has been shown to be a strong predictor of all-cause 197 mortality 34 . When looking at cause-specific mortalities, the strongest associations for with red 198 wine were observed with reduced risk of cancer and other-cause mortalities, in both unadjusted 199 and multivariate-adjusted models. The lack of beneficial association with cardiovascular disease 200 may be due to the cohort characteristics itself, namely the low cardiovascular disease mortality 201 rate in this middle aged female population. 202
In contrast to the beneficial whole foods listed above, which are rich sources of flavan-3-ols, 203 proanthocyanins and anthocyanins, the foods rich in flavanones showed markedly different 204 results. Oranges showed no association with all-cause mortality, and grapefruit had a small 205 positive association with all-cause mortality. This inverse association may be due to the 206 contribution of sugar-rich juices to total grapefruit intake. Furthermore, this detrimental 207 association may also be explained by be due to the findings that grapefruit components have 208 clinically significant interactions with drugs, which appear to be independent of their flavonoid 209 content 35 . However, this hypotheses were unable to be explored in this cohort. 210
We observed that flavonoid-rich whole foods, and not flavonoid subclasses, showed the strongest 211 associations with risk of all-cause mortality. Although not reaching statistical significance, many 212 of the flavonoid subclasses followed similar trends to that of their predominant whole food 213 constituents. For example, the positive and null associations of flavanone-rich grapefruit and 214 oranges, respectively, were reflected in a non-significant trend in the multivariate-adjusted model 215 whereby high flavanone consumers tended to have higher mortality rates. Conversely, the 216 beneficial associations of anthocyanin-rich blueberries and strawberries was reflected in a no-217 significant observed trend high anthocyanin consumers tended to have lower mortality rates. The 218 role of the whole-food in influencing relationships has not yet been fully elucidated, and results 219 from the literature are conflicting. In understanding the strength of association differences at a 220 whole food level as opposed to a compound level, it is important to note that flavonoid intake 221 estimates are derived from intake data for many different individual food items, the majority of 222 which were not included in our study, which only looked at foods which contribute substantially 223 to flavonoid-class intake. The importance of whole foods, as opposed to isolated nutrients, are 224 becoming increasingly recognized for public health guidelines and dietary recommendations 28 . 225
Although results were not substantially altered by conducting sensitivity analyses, such as the lag 226 analyses, it is important to note that causality of observed relationships cannot be established due 227 to the observational nature of the study. Also, despite the inclusion of dietary and lifestyle factors 228 into statistical models, residual or unmeasured confounders cannot be ruled out. Identification of 229 causality is further limited by the complexity associated with assessing food composition and 230 dietary intake including for flavonoids 36 , which further highlights the importance of conducting 231 both nutrient-based and whole-food based analyses. 232
In summary, in this prospective cohort study of female US nurses, we found a beneficial 233 relationship between the dietary intake of select whole-food sources of flavonoids and risk of 234 mortality. Specifically, frequent consumption of blueberries, strawberries, peppers, red wine and, 235 was associated with reduced risk of all-cause mortality. These beneficial associations did not 236 extend to total-flavonoids or flavonoid subclasses, and when considering the literature as a 237 whole, future prospective association studies are warranted. 3 Total number of cancer mortalities: 887. 4 Total number of cardiovascular disease (CVD) mortalities: 189. 5 Total number of mortalities from other causes: 818.
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